XTuit Pharmaceuticals
Pioneering new methods to enhance cancer treatment by focusing on the tumor microenvironment.
Pioneering new methods to enhance cancer treatment by focusing on the tumor microenvironment.
XTuit Pharmaceuticals is a biotechnology and pharmaceutical company founded in 2011 and based in Waltham, Massachusetts. The company's slogan, "Pioneering new methods to enhance cancer treatment by focusing on the tumor microenvironment," reflects its primary focus on creating advanced pharmaceutical solutions for diagnosing and treating cancer, tumors, and inflammatory diseases. Notably, XTuit Pharmaceuticals received a significant $22.00M Series A investment on 11 June 2015, with contributions from New Enterprise Associates, Polaris Partners, Arcus Ventures, CTI Life Sciences Fund, and Omega Funds. With a clear mission and substantial backing, XTuit Pharmaceuticals is positioned to make an impact in the healthcare and biotechnology industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $22.00M | 5 |
|
11 Jun 2015 |
| Venture Round | $4.00M | - | 05 Dec 2014 |
No recent news or press coverage available for XTuit Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.
